Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-07-11

FDA Approved: JATENZO — Supplemental Application (TOLMAR Inc.)

View source ↗

Summary

FDA approved a supplemental application for JATENZO (testosterone undecanoate) from Tolmar Inc., signaling an approval of a change to the NDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • JATENZO (testosterone undecanoate)

Snippet

SUPPL AP for JATENZO (TESTOSTERONE UNDECANOATE)